What 2bPrecise does

2bPrecise Technologies LLC is a private US healthcare technology company founded in 2016 that delivers an enterprise precision medicine platform integrating genomic and clinical data directly into Electronic Health Record (EHR) workflows at the point of care. The company is headquartered in Houston, Texas (with firmographic references to Pittsburgh) and operates with 11–50 employees, serving large healthcare systems, hospital networks, and oncology programs as its primary customer base. Its core technology is a modular platform with three integrated layers: (1) Point-of-care Applications including family history/pedigree visualization, patient genetic profiles, drug-gene interaction checks, and tumor profile access; (2) an 'Infusing Intelligence' module surfacing evolving knowledgebases, clinical guidelines, and customizable rules (including clinical trial matching); and (3) a Data Management and Workflow Efficiency backbone handling genomic data integration, governance, storage, and reuse across the enterprise. The platform supports two main therapeutic applications — Pharmacogenomics (safer, more effective medication selection) and Precision Oncology (somatic/germline integration for targeted therapies) — and is built around a 'test once, interrogate often' model that extends the value of germline test results across specialties and over time.

The company operates a direct enterprise field-sales motion with a 'Request Demo' CTA targeting large hospital networks and health systems, and monetizes through enterprise subscription contracts with quote-based pricing. Revenue, funding, and ownership details are not publicly disclosed, and the company is structured as an LLC with no identified parent entity, venture capital backers, or institutional investors in the source data. Recent strategic activity in 2025 includes a publicly announced enterprise deployment at Spartanburg Regional Healthcare System (June 25, 2025), a partnership with Neurogen Biomarking (May 21, 2025), and a DPYD Safety Update release (October 16, 2025) extending its pharmacogenomics capability. Leadership consists of Founder & CEO Assaf Halevy, Chief Medical Officer Joel Diamond, and Director of Operations Phillip LaJoie. The product portfolio, customer base, and go-to-market indicate a focused, niche enterprise SaaS play rather than a broadly distributed platform, with limited disclosed evidence of scale, AI-native differentiation, or external capital.

Name

2bPrecise

Legal name

2bPrecise Technologies LLC

Website

https://2bprecisehealth.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

2bPrecise Technologies is a private US healthcare technology company offering an enterprise EHR-integrated precision medicine platform that delivers point-of-care pharmacogenomics, precision oncology, and inherited condition decision support to large health systems and hospital networks via direct enterprise subscriptions.

Ownership category

akta.pro rank

Headquarters

HQ city

Pittsburgh

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Enterprise Platform Subscription: Subscription-based access to the 2bPrecise enterprise platform for healthcare organizations, with modular implementation allowing organizations to scale functionality according to priorities over time

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

2bPrecise sells an enterprise software platform that ingests, structures, and surfaces genetic, genomic, family-history, and pharmacogenomic data directly inside a healthcare organization's Electronic Health Record at the point of care. Its commercial offerings center on the 2bPrecise Enterprise Platform and two therapeutic applications built on top of it — Pharmacogenomics and Precision Oncology — delivered as subscriptions to large healthcare enterprises via direct field sales.

Product overview

2bPrecise offers a unified enterprise platform for precision medicine that integrates genetic and genomic data directly into Electronic Health Records (EHR) at the point of care. The platform architecture consists of three integrated modules: (1) Point-of-care Applications providing Family History visualization, Patient Genetic Profiles, Drug-gene Interactions, and Tumor Profile access; (2) Infusing Intelligence delivering Evolving Knowledgebases, Clinical Guidelines, and Customizable Rules for clinical trial matching; and (3) Data Management and Workflow Efficiency handling Integration, Governance, and Storage. The platform supports two primary therapeutic applications—Pharmacogenomics (for safer, more effective medication selection) and Precision Oncology (for targeted cancer therapy decisions). 2bPrecise's modular architecture allows organizations to implement functionality incrementally and scale over time, enabling the 'test once, interrogate often' model that extends the value of genetic tests across specialties.

Differentiator

Problem solved

Functional benefit

Products and services

• 2bPrecise Enterprise Platform An enterprise-spanning precision medicine platform that brings genetic and genomic test results and insights to the point of care within any Electronic Health Record (EHR), enabling scalable, modular implementation of pharmacogenomics and precision oncology workflows for healthcare organizations.
• Pharmacogenomics Solution Point-of-care pharmacogenomics application that gives clinicians fingertip access to pharmacogenomic test results inside the EHR, helping identify medications that are safer and more effective and eliminating 'trial-and-error' prescribing practices for health-system customers implementing pharmacogenomics programs.
• Precision Oncology Solution Precision oncology application that integrates somatic and germline test results — including tumor profiles — directly into the clinician's EHR workflow, enabling targeted-therapy selection and clinical-trial matching while eradicating 'PDF chase' workflows for healthcare systems with oncology programs.

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Neurogen Biomarkingnot specifiedStrategic or Co-development Partner · 21 May 2025Partnership announced May 21, 2025 with Neurogen Biomarking. Details of the partnership collaboration were not specified in the source material beyond the announcement.

Recent moves4 records

Expansion highlights4 records

Direct peers

• Syapse: Syapse provides a precision oncology real-world data and clinical decision support platform used by health systems. Like 2bPrecise, it sits between molecular testing and the EHR to operationalize genomic insights in clinical workflows.
• Molecular Health: Molecular Health offers a clinical decision support platform (MolecularHealthGuide) for interpreting genomic and drug-response data to guide therapy choices. It directly competes with 2bPrecise's drug-gene interactions and tumor profile workflows.
• Translational Software: Translational Software provides pharmacogenomics clinical decision support integrated with EHRs to flag drug-gene interactions at the point of prescribing. It competes head-to-head with 2bPrecise's pharmacogenomics module for health system contracts.
• Intelligent Medical Objects (IMO): IMO provides clinical terminology and data-quality solutions that integrate into EHR workflows at scale. While it operates upstream of 2bPrecise's genomic decision support, both companies compete for similar EHR-integration real estate within health system IT budgets.

Broad incumbents

• Foundation Medicine: Foundation Medicine (a Roche subsidiary) provides comprehensive genomic profiling for oncology and is integrated into EHR workflows via partnerships. It competes with 2bPrecise's Precision Oncology use case from the lab and report-delivery side.
• Tempus Labs: Tempus combines genomic sequencing, a molecular data library, and AI-driven clinical decision support. It overlaps with 2bPrecise's pharmacogenomics and precision oncology positioning but operates a broader vertically-integrated model spanning lab services and software.
• Optum (UnitedHealth Group): Optum operates clinical decision support, analytics, and care management platforms serving health systems and payers. Its breadth across the healthcare value chain and capital scale make it a credible indirect competitor for enterprise precision medicine budgets.
• Epic Systems: Epic is the dominant hospital EHR vendor and offers its own genomics and precision medicine capabilities through Cosmos and other modules. As the platform layer on which 2bPrecise runs, Epic represents both a key partner and a latent competitive threat.
• Oracle Health (formerly Cerner): Oracle Health provides one of the two largest hospital EHR platforms and has been expanding into genomics and precision medicine workflows. Its installed base overlaps directly with 2bPrecise's target customers and represents both a deployment surface and a competitive threat.

Emerging players

• PhenoTips: PhenoTips provides pedigree drawing, family history capture, and rare disease case management tools for clinical genetics workflows. It overlaps with 2bPrecise's Inherited Conditions module but focuses more narrowly on the genetics clinic use case.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Xx.com/2bPrecise
• LinkedInlinkedin.com/company/2bprecise

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 2bPrecise